Form 8-K - Current report:
SEC Accession No. 0001213900-25-029501
Filing Date
2025-04-08
Accepted
2025-04-07 17:40:47
Documents
15
Period of Report
2025-04-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0237298-8k_inmed.htm   iXBRL 8-K 26998
2 SEDAR FILING SUBMITTED APRIL 4, 2025 ea023729801ex99-1_inmed.htm EX-99.1 8836
3 GRAPHIC ex99-1_001.jpg GRAPHIC 17581
  Complete submission text file 0001213900-25-029501.txt   235336

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20250404.xsd EX-101.SCH 3020
5 XBRL LABEL FILE inm-20250404_lab.xml EX-101.LAB 34239
6 XBRL PRESENTATION FILE inm-20250404_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT ea0237298-8k_inmed_htm.xml XML 3670
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 25819177
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)